瘤细胞代谢重编程和缺氧免疫抑制:驱动致癌症到转移殖民的转移
Theodora Katopodi1, Savvas Petanidis1,2, Doxakis Anestakis3
1Department of Medicine, Laboratory of Medical Biology and Genetics, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Frontiers in immunology
|January 31, 2024
概括
癌细胞和免疫细胞重编程新陈代谢,影响抗瘤免疫力. 针对这些代谢途径提供了新的策略,以提高癌症免疫治疗的有效性.
科学领域:
- 免疫学 免疫学 免疫学
- 癌症生物学 癌症生物学
- 代谢研究研究 代谢研究
背景情况:
- 癌症和免疫细胞中的代谢重编程显著影响抗瘤免疫反应.
- 癌症代谢影响癌症信号传递,生存和免疫调节因子的表达,如乳酸和IDO.
- 瘤微环境表现出代谢竞争,导致酸性,损害免疫细胞功能.
研究的目的:
- 通过对癌症和免疫细胞的代谢重编程来审查抗瘤免疫的调节.
- 探索针对癌症免疫治疗中的代谢途径的潜在策略.
- 讨论联合免疫疗法-代谢干预措施,以提高治疗疗效.
主要方法:
- 文献综述和综合有关癌症代谢和免疫学的当前研究.
- 分析瘤微环境中的细胞代谢和免疫细胞功能之间的相互作用.
- 确定关键的代谢途径和参与免疫逃避和反应的因素.
主要成果:
- 代谢重编程对于癌细胞生存和免疫逃避至关重要.
- 免疫细胞也经历代谢重编程,以维持平衡和效应器功能.
- 瘤生态系统内的代谢竞争创造了一个免疫抑制的环境.
结论:
- 代谢重编程是抗瘤免疫反应的关键调节者.
- 准癌症和免疫细胞代谢是一个有前途的治疗策略.
- 涉及免疫疗法和代谢干预的组合疗法可以提高治疗结果.
相关概念视频
02:53Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
02:17The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
02:30Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
02:49Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
01:27Tumor Immunotherapy
526
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
526
02:40Cancer Stem Cells and Tumor Maintenance
4.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.9K